Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Reprod Fertil Dev ; 26(8): 1084-93, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23981671

RESUMEN

Meiosis produces haploid gametes for sexual reproduction. Triphenyltin chloride (TPTCL) is a highly bioaccumulated and toxic environmental oestrogen; however, its effect on oocyte meiosis remains unknown. We examined the effect of TPTCL on mouse oocyte meiotic maturation in vitro and in vivo. In vitro, TPTCL inhibited germinal vesicle breakdown (GVBD) and first polar body extrusion (PBE) in a dose-dependent manner. The spindle microtubules completely disassembled and the chromosomes condensed after oocytes were exposed to 5 or 10µgmL(-1) TPTCL. γ-Tubulin protein was abnormally localised near chromosomes rather than on the spindle poles. In vivo, mice received TPTCL by oral gavage for 10 days. The general condition of the mice deteriorated and the ovary coefficient was reduced (P<0.05). The number of secondary and mature ovarian follicles was significantly reduced by 10mgkg(-1) TPTCL (P<0.05). GVBD decreased in a non-significant, dose-dependent manner (P>0.05). PBE was inhibited with 10mgkg(-1) TPTCL (P<0.05). The spindles of in vitro and in vivo metaphase II oocytes were disassembled with 10mgkg(-1) TPTCL. These results suggest that TPTCL seriously affects meiotic maturation by disturbing cell-cycle progression, disturbing the microtubule cytoskeleton and inhibiting follicle development in mouse oocytes.


Asunto(s)
Meiosis/efectos de los fármacos , Microtúbulos/efectos de los fármacos , Oocitos/efectos de los fármacos , Compuestos Orgánicos de Estaño/toxicidad , Huso Acromático/efectos de los fármacos , Actinas/metabolismo , Animales , Puntos de Control del Ciclo Celular/efectos de los fármacos , Células Cultivadas , Segregación Cromosómica/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Metafase/efectos de los fármacos , Ratones Endogámicos ICR , Microtúbulos/metabolismo , Microtúbulos/patología , Oocitos/metabolismo , Oocitos/patología , Cuerpos Polares/efectos de los fármacos , Cuerpos Polares/metabolismo , Cuerpos Polares/patología , Huso Acromático/metabolismo , Huso Acromático/patología , Factores de Tiempo , Tubulina (Proteína)/metabolismo
2.
Animals (Basel) ; 14(3)2024 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-38338092

RESUMEN

Eupatilin (5,7-dihydroxy-3',4',6-trimethoxyflavone) is a flavonoid derived from Artemisia plants that has beneficial biological activities, such as anti-apoptotic, anti-oxidant, and anti-inflammatory activities. However, the protective effects of eupatilin against oxidative stress and endoplasmic reticulum stress in porcine oocyte maturation are still unclear. To investigate the effect of eupatilin on the development of porcine oocytes after in vitro maturation and parthenogenetic activation, we added different concentrations of eupatilin in the process of porcine oocyte maturation in vitro, and finally selected the optimal concentration following multiple comparisons and analysis of test results using SPSS (version 17.0; IBM, Chicago, IL, USA) software. The results showed that 0.1 µM eupatilin supplementation did not affect the expansion of porcine cumulus cells, but significantly increased the extrusion rate of porcine oocyte polar bodies, the subsequent blastocyst formation rate, and the quality of parthenogenetically activated porcine embryos. Additionally, it reduced the level of reactive oxygen species in cells and increased glutathione production. Further analysis revealed that eupatilin supplementation could reduce apoptosis, DNA double-strand breaks, and endoplasmic reticulum stress. In conclusion, supplementation with 0.1 µM eupatilin during in vitro maturation improved oocyte maturation and subsequent embryo development by reducing oxidative stress and endoplasmic reticulum stress.

3.
Fertil Steril ; 102(1): 264-71, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24835059

RESUMEN

OBJECTIVE: To study the role of lipoxin A4 (LXA4) in endometriosis. DESIGN: Molecular analysis in human samples and primary human endometriotic stromal cells (ESCs). SETTING: University hospital. PATIENT(S): Forty-nine premenopausal women (30 patients with endometriosis and 19 controls). INTERVENTION(S): Normal and ectopic endometrial biopsies obtained during surgery performed during the proliferative phase of the menstrual cycle; ESCs used for in vitro studies. MAIN OUTCOME MEASURE(S): Levels of LXA4 measured by enzyme-linked immunosorbent assay (ELISA); mRNA levels of the estrogen receptor (ER), progestogen receptor (PR), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) quantified by quantitative reverse-transcription polymerase chain reaction (qRT-PCR); and p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation evaluated by Western blotting. RESULT(S): The LXA4 expression level decreased in ectopic tissue as well as ERα and PR, although the expression of ERß increased in ectopic endometrium compared with the controls. Investigations with correlation analysis revealed the expression of LXA4 was positively correlated with ERα and negatively correlated with ERß in vivo. Moreover, administering LXA4 could augment ERß expression in ESCs and inhibit the 17ß-estradiol-induced phosphorylation of p38 MAPK very likely through ERß. CONCLUSION(S): Our findings indicate that LXA4 regulates ERß expression and inhibits 17ß-estradiol-induced phosphorylation of p38 MAPK, very likely through ERß in ESCs.


Asunto(s)
Endometriosis/enzimología , Endometrio/enzimología , Estradiol/metabolismo , Receptor beta de Estrógeno/genética , Lipoxinas/metabolismo , Células del Estroma/enzimología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Adulto , Estudios de Casos y Controles , Células Cultivadas , Endometriosis/genética , Activación Enzimática , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/metabolismo , Femenino , Humanos , Interleucina-6/genética , Interleucina-6/metabolismo , Persona de Mediana Edad , Fosforilación , ARN Mensajero/metabolismo , Receptores de Progesterona/genética , Receptores de Progesterona/metabolismo , Transducción de Señal , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Adulto Joven
4.
PLoS One ; 8(10): e77960, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24194906

RESUMEN

Methylglyoxal, a reactive dicarbonyl compound, is mainly formed from glycolysis. Methylglyoxal can lead to the dysfunction of mitochondria, the depletion of cellular anti-oxidation enzymes and the formation of advanced glycation ends. Previous studies showed that the accumulation of methylglyoxal and advanced glycation ends can impair the oocyte maturation and reduce the oocyte quality in aged and diabetic females. In this study, we showed that resveratrol, a kind of phytoalexin found in the skin of grapes, red wine and other botanical extracts, can alleviate the adverse effects caused by methylglyoxal, such as inhibition of oocyte maturation and disruption of spindle assembly. Besides, methylglyoxal-treated oocytes displayed more DNA double strands breaks and this can also be decreased by treatment of resveratrol. Further investigation of these processes revealed that methylglyoxal may affect the oocyte quality by resulting in excessive reactive oxygen species production, aberrant mitochondrial distribution and high level lipid peroxidation, and resveratrol can block these cytotoxic changes. Collectively, our results showed that resveratrol can protect the oocytes from methylglyoxal-induced cytotoxicity and this was mainly through the correction of the abnormity of cellular reactive oxygen species metabolism.


Asunto(s)
Productos Finales de Glicación Avanzada/efectos adversos , Oocitos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Piruvaldehído/efectos adversos , Estilbenos/farmacología , Análisis de Varianza , Animales , Roturas del ADN de Doble Cadena/efectos de los fármacos , Femenino , Técnica del Anticuerpo Fluorescente , Productos Finales de Glicación Avanzada/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Ratones , Microscopía Confocal , Piruvaldehído/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Resveratrol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA